| Literature DB >> 33537938 |
Mónica Méndez-Díaz1, Alejandra E Ruiz-Contreras2, Jacqueline Cortés-Morelos3, Oscar Prospéro-García4.
Abstract
The sleep-wake cycle is a complex process that includes wake (W), non-rapid-eye-movement (NREM) and rapid-eye-movement (REM) sleep. Each phase is regulated by specialized brain structures that, by means of different neurotransmitters, maintain the constant expression of the sleep-wake cycle. Molecules like orexin, serotonin, noradrenaline, histamine, for waking; GABA, adenosine, prostaglandins, for NREM sleep and acetylcholine and glutamate for REM sleep, among other molecules are responsible for the expression and maintenance of each phase. When the endocannabinoid system was being described for the first time, almost three decades ago, oleamide's sleep promoting properties were highlighted. Nowadays, enough evidence has been cumulated to support the endocannabinoid system role in the sleep-wake cycle regulation. The endocannabinoids oleamide anandamide, and 2-arachidonylglycerol promote NREM and/or REM sleep via the CB1R, thereby making this system a target to treat sleep disorders, such as insomnia.Entities:
Keywords: 2-arachidonylglycerol; Anadamide; Cannabinoid receptor 1; Insomnia; Non-rapid-eye-movement (NREM) sleep; Oleamide; Rapid-eye-movement (REM) sleep
Year: 2021 PMID: 33537938 DOI: 10.1007/978-3-030-61663-2_6
Source DB: PubMed Journal: Adv Exp Med Biol ISSN: 0065-2598 Impact factor: 2.622